
Week 6: Regulatory Shifts, Tariff Action & Industry Feedback
USTR proposes new China tariffs; FDA, CMS, and White House actions could reshape MedTech—member input needed by June 10.
USTR proposes new China tariffs; FDA, CMS, and White House actions could reshape MedTech—member input needed by June 10.
White House tariff actions, DOJ and CMS RFIs, and USTR investigations headline Week 5—member feedback needed this month.